These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 201542)

  • 1. The influence of dihydroergotoxine mesylate on the low-Km phosphodiesterase of cat and rat brain in vitro.
    Enz A; Iwangoff P; Chappuis A
    Gerontology; 1978; 24 Suppl 1():115-25. PubMed ID: 201542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hydergine on the enzymes involved in cAMP turonver in the brain.
    Enz A; Iwangoff P; Markstein R; Wagner H
    Triangle; 1975; 14(2):90-2. PubMed ID: 173058
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
    Whalin ME; Garrett RL; Thompson WJ; Strada SJ
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of beef cortex membrane-bound 3', 5'-AMP phosphodiesterase by halogenated purines.
    Macdonald IA
    Pharmacol Res Commun; 1977 Jan; 9(1):49-58. PubMed ID: 194263
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
    Du Moulin A; Schultz J
    Experientia; 1975 Aug; 31(8):883-4. PubMed ID: 169139
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of nicergoline on reaction kinetics of various forms of cyclic AMP phosphodiesterase.
    Pericin D; Leskovac V
    Arzneimittelforschung; 1981; 31(12):2082-5. PubMed ID: 6277342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro inhibition of cyclic 3' 5',-AMP-phosphodiesterase by a group of structural analogues of glaucine.
    Petkov V; Stancheva S
    Acta Physiol Pharmacol Bulg; 1980; 6(3):38-47. PubMed ID: 6269351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain low-Km cAMP phosphodiesterase.
    de Mazancourt P; Giudicelli Y
    Methods Enzymol; 1988; 159():766-72. PubMed ID: 2842640
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of psychotropic preparations on cyclic AMP phosphodiesterase activity in the rat cerebral cortex].
    Shchekoldina TG; Vatolkina OE; Libinzon RE
    Vopr Med Khim; 1978; 24(2):166-9. PubMed ID: 208286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
    Schwabe U; Miyake M; Ohga Y; Daly JW
    Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calmodulin sensitive phosphodiesterase of porcine cerebral cortex: kinetic behavior, calmodulin activation, and stability.
    Keravis TM; Duemler BH; Wells JN
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):365-72. PubMed ID: 3040819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic parameters of 3',5'-cAMP phosphodiesterase in cat sciatic nerve.
    Curley WH; Standaert FG; Dretchen KL
    Biochem Pharmacol; 1983 Jan; 32(1):162-4. PubMed ID: 6299296
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormonal regulation of adipocyte particulate "low Km" cAMP phosphodiesterase.
    Manganiello VC; Smith CJ; Newman AH; Rice K; Degerman E; Belfrage P
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):497-511. PubMed ID: 2450112
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological aspects of dihydrogenated ergot alkaloids in experimental brain research.
    Meier-Ruge W; Emmenegger H; Enz A; Gygax P; Iwangoff P; Wiernsperger N
    Pharmacology; 1978; 16 Suppl 1():45-62. PubMed ID: 205890
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of tricyclic antidepressants on the adenylate cyclase-phosphodiesterase system in the rat cortex.
    Palmer GC
    Neuropharmacology; 1976 Jan; 15(1):1-7. PubMed ID: 176608
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Properties of 3',5' c-AMP phosphodiesterase in the cerebral cortex of guinea pigs and the effect of heptacaine].
    Brechtlová M; Líska B; Krizko J; Uhlíková E; Cizmárik J
    Cesk Fysiol; 1984; 33(2):114-8. PubMed ID: 6327089
    [No Abstract]   [Full Text] [Related]  

  • 20. Dihydroergotoxine-induced modulation of spontaneous activity of cultured rat Purkinje cells.
    Gähwiler BH
    Gerontology; 1978; 24 Suppl 1():71-5. PubMed ID: 618780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.